端粒、端粒酶、shelterin与获得性再生障碍性贫血的研究概况
摘要
再生障碍性贫血(Aplastic anemia,AA,简称再障)是由多种原因引起的造血干细胞数量下降和功能异常,导致全血细胞减少的一种综合病症,是骨髓衰竭综合征的一种。AA可以分为获得性和遗传性的,
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2012年第9期854-857,共4页
Chinese Journal of Immunology
基金
国家"十一五"科技支撑计划项目(2007BAI20B06)
参考文献25
-
1Raynaud C M, Sabatier L,Philipot 0 et al. Telomere length, telomer- ic proteins and genomic instability during the multistep carcinogenic process [ J ]. Crit Rev Oncol Hemato1,2008 ;66 (2) :99-117.
-
2Brummendorf T H ,Macie jewski J P,Mak J et al. Telomere length in leukocyte subpopulations of patients with aplastic anemia [ J ]. Blood, 2001 ;97(4) :895-900.
-
3Lee J J, Kook H, Chung I J et al. Telomere length changes in patients with aplastic anaemia[J]. Br J Haemato1,2001 ; 112 (4) : 1025-1030.
-
4Scheinberg P, Cooper J N, Sloand E Met al. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, ma- lignant transformation, and survival in severe aplastic anemia [ J ]. JAMA,2010 ;304(12) : 1358-1364.
-
5Ball S E, Gibson F M, Rizzo Set al. Progressive telomere shortening in aplastic anemia[ J ]. Blood, 1998 ;91 (10) :3582-3592.
-
6Li X, Leteurtre F, Rocha Vet al. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the proba- bility of developing severe aplastic anaemia[ J]. Br J Haemato1,2003 ; 120(5 ) :836-845.
-
7Young N S. Telomere biology and telomere diseases: implications for practice and research [ J ]. Hematology Am Soc Hematol Educ Pro- gram,2010:30-35.
-
8Young N S, Bacigalupo A, Marsh J C. Aplastic anemia : pathophysiol- ogy and treatment [J]. Biol Blood Marrow Transplant,2010;16 (1) : Sl19-125.
-
9Yamaguchi H, Calado R T, Ly H et al. Mtltations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia[J]. N Engl J Med, 2005 ;352 ( 14 ) : 1413-1424.
-
10Xin Z T, Beauchamp A D, Calado R T et al. Functional characteriza- tion of natural telomerase mutations found in patients with hemato- logical disorders[ J]. Blood, 2007 ; 109 ( 2 ) :524-532.
-
1何薇,谢晓恬.获得性再生障碍性贫血发病机制研究最新进展[J].中华实用儿科临床杂志,2016,31(3):238-240. 被引量:3
-
2儿童获得性再生障碍性贫血在免疫抑制治疗后进展为骨髓增生异常综合征和急性髓性白血病的危险因素[J].中华医学信息导报,2002,17(16):13-13.
-
3黄素芳,冷淑梅,刘喜荣.获得性再生障碍性贫血45例临床分析[J].哈尔滨医科大学学报,1998,32(1):64-65.
-
4许政刚.谨防漏诊痛风[J].长寿,2001,0(2):35-35.
-
5耿引红.社区开展糖尿病健康教育198例疗效观察[J].社区医学杂志,2009,7(22):46-47. 被引量:1
-
6马成芳,王梅.85例肝昏迷的护理体会[J].工企医刊,2006,19(1):51-52.
-
7肖云季.艾滋病或已传播百年[J].医药前沿,2012(1):20-20.
-
8刘荣.再生障碍性贫血并发出血的护理[J].中国误诊学杂志,2007,7(14):3288-3288. 被引量:3
-
9刘家庆,朱玉霞.获得性再生障碍性贫血的免疫发病机制[J].中国医学创新,2012,9(6):156-158. 被引量:1
-
10王耀平.获得性再生障碍性贫血发病机制及治疗进展[J].实用医院临床杂志,2008,5(4):34-36.